Nectar Lifesciences is currently trading at Rs. 42.60, up by 0.80 points or 1.91% from its previous closing of Rs. 41.80 on the BSE.
The scrip opened at Rs. 42.50 and has touched a high and low of Rs. 44.00 and Rs. 42.35 respectively. So far 310607 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 44.65 on 16-Sep-2014 and a 52 week low of Rs. 18.10 on 19-Mar-2014.
Last one week high and low of the scrip stood at Rs. 44.00 and Rs. 35.00 respectively. The current market cap of the company is Rs. 968.81 crore.
The promoters holding in the company stood at 44.35% while Institutions and Non-Institutions held 14.62% and 20.51% respectively.
Nectar Lifesciences has been chosen as the Fastest Growing Pharmaceutical Company in 2014 by CNBC TV-18 in partnership with State Bank of India (SBI) during the 5th edition international trade awards held in Ludhiana. The advisors for this award were ICRA. The citation was awarded under Aegis of Export Import Forum of India. The company has maintained a CAGR of 25% for last 10 years.
Nectar Lifesciences is a $311 million pharmaceutical organization. The company offers a range of Cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: